This company is now a one-trick pony, with superior drugs like Nexavar showing greater efficacy over a much wider range of conditions.
Most analysts are rating this one a strong sell.
lung cancer trial fails
-
- There are more pages in this discussion • 15 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PGL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
44.0¢ |
Change
-0.005(1.12%) |
Mkt cap ! $72.48M | |||
| Open | High | Low | Value | Volume |
| 44.5¢ | 44.5¢ | 44.0¢ | $226.1K | 509.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 959885 | 44.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 45.0¢ | 277803 | 10 |
View Market Depth
| Last trade - 14.08pm 23/07/2024 (20 minute delay) ? |
| PGL (ASX) Chart |